BIO
Bio-Rad Laboratories, Inc.Company with tickers: BIO, BIO-B
CIK
12208
CUSIP
090572207
Shares Outstanding
21,700,560
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $592,100,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | — | ||||
| Gross Profit | $309,400,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Expenses | — | ||||
| Research & Development | $62,900,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $34,100,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $-527,100,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $-19.55 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $-19.55 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |